(Q38837353)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28409203%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

publication date

13 April 2017

1 reference

6 September 2017

Intensive Care Medicine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28409203%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

volume

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28409203%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

page(s)

1021-1032

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28409203%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28409203%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00134-017-4780-6

6 June 2020

exact match

0 references

cites work

Impact of Policies on the Rise in Sepsis Incidence, 2000-2010

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4780-6

International study of the prevalence and outcomes of infection in intensive care units

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4780-6

Clinical implications of antibiotic pharmacokinetic principles in the critically ill.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4780-6

Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4780-6

Use of old antibiotics now and in the future from a pharmacokinetic/pharmacodynamic perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4780-6

The role of pharmacokinetics/pharmacodynamics in setting clinical MIC breakpoints: the EUCAST approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4780-6

Restricting the selection of antibiotic-resistant mutants: a general strategy derived from fluoroquinolone studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4780-6

Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4780-6

Antimicrobial pharmacodynamics: critical interactions of 'bug and drug'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4780-6

Pharmacological indices in antibiotic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4780-6

Standardization of pharmacokinetic/pharmacodynamic (PK/PD) terminology for anti-infective drugs: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4780-6

Clinically relevant plasma concentrations of colistin in combination with imipenem enhance pharmacodynamic activity against multidrug-resistant Pseudomonas aeruginosa at multiple inocula

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4780-6

In vitro pharmacodynamic models to determine the effect of antibacterial drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4780-6

The relationship between quinolone exposures and resistance amplification is characterized by an inverted U: a new paradigm for optimizing pharmacodynamics to counterselect resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4780-6

Pharmacodynamics of early, high-dose linezolid against vancomycin-resistant enterococci with elevated MICs and pre-existing genetic mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4780-6

Effect of different renal function on antibacterial effects of piperacillin against Pseudomonas aeruginosa evaluated via the hollow-fibre infection model and mechanism-based modelling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4780-6

Pharmacokinetic-pharmacodynamic modeling of antibacterial drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4780-6

Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of β-lactams

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4780-6

Augmented renal clearance: implications for antibacterial dosing in the critically ill.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4780-6

Improving antibiotic dosing in special situations in the ICU: burns, renal replacement therapy and extracorporeal membrane oxygenation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4780-6

Principles of antibacterial dosing in continuous renal replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4780-6

Pharmacokinetic changes in patients receiving extracorporeal membrane oxygenation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4780-6

Plasma and target-site subcutaneous tissue population pharmacokinetics and dosing simulations of cefazolin in post-trauma critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4780-6

Antifungal pharmacokinetics and pharmacodynamics: bridging from the bench to bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4780-6

Population pharmacokinetics of teicoplanin in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4780-6

Optimal sampling schedule design for populations of patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4780-6

Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: distribution in tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4780-6

Impaired target site penetration of beta-lactams may account for therapeutic failure in patients with septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4780-6

Tissue concentrations: do we ever learn?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4780-6

Microdialysis as a way to measure antibiotics concentration in tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4780-6

Microdialysis study of cefotaxime cerebral distribution in patients with acute brain injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4780-6

Kinetics of imipenem distribution into the peritoneal fluid of patients with severe peritonitis studied by microdialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4780-6

Penetration of gentamicin into the alveolar lining fluid of critically ill patients with ventilator-associated pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4780-6

Plasma and lung concentrations of ceftazidime administered in continuous infusion to critically ill patients with severe nosocomial pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4780-6

Steady-state plasma and intrapulmonary concentrations of cefepime administered in continuous infusion in critically ill patients with severe nosocomial pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4780-6

Penetration of meropenem into pneumonic human lung tissue as measured by in vivo microdialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4780-6

Penetration of piperacillin and tazobactam into pneumonic human lung tissue measured by in vivo microdialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4780-6

A pilot study testing whether concentrations of levofloxacin in interstitial space fluid of soft tissues may serve as a surrogate for predicting its pharmacokinetics in lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4780-6

Analysis of vancomycin entry into pulmonary lining fluid by bronchoalveolar lavage in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4780-6

Tissue penetration and pharmacokinetics of tigecycline in diabetic patients with chronic wound infections described by using in vivo microdialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4780-6

In vivo microdialysis study of the penetration of daptomycin into soft tissues in diabetic versus healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4780-6

Pharmacokinetics and intrapulmonary concentrations of linezolid administered to critically ill patients with ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4780-6

Interpreting population pharmacokinetic-pharmacodynamic analyses - a clinical viewpoint.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4780-6

Fundamentals of Population Pharmacokinetic Modelling : Modelling and Software

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4780-6

Use of preclinical data for selection of a phase II/III dose for evernimicin and identification of a preclinical MIC breakpoint

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4780-6

Simulation-Based Evaluation of PK/PD Indices for Meropenem Across Patient Groups and Experimental Designs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4780-6

Clinical pharmacodynamics of meropenem in patients with lower respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4780-6

Penetration of meropenem into epithelial lining fluid of patients with ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4780-6

Cefepime free minimum concentration to minimum inhibitory concentration (fCmin/MIC) ratio predicts clinical failure in patients with Gram-negative bacterial pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4780-6

Toxicodynamics of itraconazole: implications for therapeutic drug monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4780-6

Are vancomycin trough concentrations adequate for optimal dosing?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4780-6

What about confidence intervals? A word of caution when interpreting PTA simulations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4780-6

Vancomycin dosing in critically ill patients: robust methods for improved continuous-infusion regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4780-6

New Regimen for Continuous Infusion of Vancomycin in Critically Ill Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4780-6

Comparison of the accuracy and precision of pharmacokinetic equations to predict free meropenem concentrations in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4780-6

Therapeutic drug monitoring of anti-infective agents in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4780-6

Combination therapy for carbapenem-resistant Gram-negative bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4780-6

Front-loaded linezolid regimens result in increased killing and suppression of the accessory gene regulator system of Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4780-6

Population pharmacokinetics of fusidic acid: rationale for front-loaded dosing regimens due to autoinhibition of clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4780-6

Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4780-6

Daptomycin exposure and the probability of elevations in the creatine phosphokinase level: data from a randomized trial of patients with bacteremia and endocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4780-6

Vancomycin-associated nephrotoxicity in the critically ill: a retrospective multivariate regression analysis*.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4780-6

Clinical population pharmacokinetics and toxicodynamics of linezolid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4780-6

Efficacy, nephrotoxicity and ototoxicity of aminoglycosides, mathematically modelled for modelling-supported therapeutic drug monitoring.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4780-6

Population pharmacokinetic and pharmacodynamic analysis of linezolid and a hematologic side effect, thrombocytopenia, in Japanese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4780-6

Population pharmacokinetics and pharmacodynamics of teicoplanin in neonates: making better use of C-reactive protein to deliver individualized therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-017-4780-6

Tree-Based Models for Predicting Mortality in Gram-Negative Bacteremia: Avoid Putting the CART before the Horse.

21 January 2018

1 reference

12 December 2020

The impact of multidrug resistance on the outcomes of critically ill patients with Gram-negative bacterial pneumonia

1 reference

12 December 2020

An artificial capillary in vitro kinetic model of antibiotic bactericidal activity

1 reference

12 December 2020

Extended versus bolus infusion of meropenem and piperacillin: a pharmacokinetic analysis

1 reference

12 December 2020

A problem in the interpretation of beta-lactam antibiotic levels in tissues

1 reference

12 December 2020

Use of C-reactive protein to guide duration of empiric antibiotic therapy in suspected early neonatal sepsis

1 reference

12 December 2020

10.1007/S00134-017-4780-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28409203%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

1 reference